Accès ouvert
2025
article
OpenAlex
Erica A. Green, Qiang Fu, Nelson Ndhairo, Thomas M Leibiger et autres
Recombinant adeno associated virus (rAAV) vectors have become popular delivery vehicles for in vivo gene therapies, but demand for rAAVs continues to outpace supply. Platform processes for rAAV production are being developed by many manufacturers, and transient chemical transfection of human embryonic …
us
(code pays fourni par la source)
Accès ouvert
2024
article
OpenAlex
Thomas M Leibiger, Luke A. Remmler, Erica A. Green, Kelvin H. Lee
Faster and more accurate analytical methods are needed to support the advancement of recombinant adeno-associated virus (rAAV) production systems. Recently, biolayer interferometry (BLI) has been developed for high-throughput AAV capsid titer measurement by functionalizing the AAVX ligand onto biosensor probes (AAVX-BLI). In …
us
(code pays fourni par la source)
Accès ouvert
2023
article
OpenAlex
Qiang Fu, Yong Suk Lee, Erica A. Green, Yongdan Wang et autres
Recombinant adeno-associated virus (rAAV) vectors are a promising platform for in vivo gene therapies. However, cost-effective, well-characterized processes necessary to manufacture rAAV therapeutics are challenging to develop without an understanding of how process parameters (PPs) affect rAAV product quality attributes (PQAs). In …
us
(code pays fourni par la source)
Accès ouvert
2021
review
OpenAlex
Erica A. Green, Kelvin H. Lee
us
(code pays fourni par la source)